Capital Reduction Following Rehabilitation Plan Approval
- Capital reduction decided following rehabilitation plan approval by Seoul Bankruptcy Court on May 12, 2026
- Sequential implementation of debt-to-equity swap (May 19), share consolidation (May 27), and third-party allotment capital increase (May 28)
- Fractional shares under 1 share from consolidation will be cancelled without compensation per court approval
- Specific reduction ratio, capital changes, and other figures were not disclosed
ADVERTISEMENT (250px+)
KOSDAQ Filing Information
- Filing: Current Report (Capital Reduction Decision)
- Company: UNION KOREA PHARM (080720)
- Submission: UNION KOREA PHARM CO.,Ltd
- Receipt: 05-19-2026